BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23154208)

  • 1. The specificity of urinary aquaporin 1 and perilipin 2 to screen for renal cell carcinoma.
    Morrissey JJ; Kharasch ED
    J Urol; 2013 May; 189(5):1913-20. PubMed ID: 23154208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study.
    Morrissey JJ; Mellnick VM; Luo J; Siegel MJ; Figenshau RS; Bhayani S; Kharasch ED
    JAMA Oncol; 2015 May; 1(2):204-12. PubMed ID: 26181025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary concentrations of aquaporin-1 and perilipin-2 in patients with renal cell carcinoma correlate with tumor size and stage but not grade.
    Morrissey JJ; Mobley J; Song J; Vetter J; Luo J; Bhayani S; Figenshau RS; Kharasch ED
    Urology; 2014 Jan; 83(1):256.e9-14. PubMed ID: 24239027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine aquaporin 1 and perilipin 2 differentiate renal carcinomas from other imaged renal masses and bladder and prostate cancer.
    Morrissey JJ; Mobley J; Figenshau RS; Vetter J; Bhayani S; Kharasch ED
    Mayo Clin Proc; 2015 Jan; 90(1):35-42. PubMed ID: 25572193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary biomarkers for the early diagnosis of kidney cancer.
    Morrissey JJ; London AN; Luo J; Kharasch ED
    Mayo Clin Proc; 2010 May; 85(5):413-21. PubMed ID: 20375178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aquaporin-1 protein levels elevated in fresh urine of renal cell carcinoma patients: potential use for screening and classification of incidental renal lesions.
    Sreedharan S; Petros JA; Master VA; Ogan K; Pattaras JG; Roberts DL; Lian F; Arnold RS
    Dis Markers; 2014; 2014():135649. PubMed ID: 24803718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for kidney cancer: is there a role for aquaporin-1 and adipophilin?
    Grebe SK; Erickson LA
    Mayo Clin Proc; 2010 May; 85(5):410-2. PubMed ID: 20435833
    [No Abstract]   [Full Text] [Related]  

  • 8. Urinary aquaporin 1 and perilipin 2: Can these novel markers accurately characterize small renal masses and help guide patient management?
    Song JB; Morrissey JJ; Mobley JM; Figenshau KG; Vetter JM; Bhayani SB; Kharasch ED; Figenshau RS
    Int J Urol; 2019 Feb; 26(2):260-265. PubMed ID: 30467901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary Biomarkers for the Detection and Management of Localized Renal Cell Carcinoma.
    Rini BI; Campbell SC
    JAMA Oncol; 2015 May; 1(2):212-3. PubMed ID: 26181026
    [No Abstract]   [Full Text] [Related]  

  • 10. Sensitivity and specificity of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 for the diagnosis of renal cell carcinoma.
    Morrissey JJ; London AN; Lambert MC; Kharasch ED
    Am J Nephrol; 2011; 34(5):391-8. PubMed ID: 21912102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioplasmonic paper-based assay for perilipin-2 non-invasively detects renal cancer.
    Hu R; Gupta R; Wang Z; Wang C; Sun H; Singamaneni S; Kharasch ED; Morrissey JJ
    Kidney Int; 2019 Dec; 96(6):1417-1421. PubMed ID: 31668633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARCHITECT® urine-neutrophil gelatinase-associated lipocalin (u-NGAL) assay as new prognostic marker for clear cell Renal Cell Carcinoma (ccRCC) (preliminary results).
    Ben Khadhra H; Rose-Robert F; Herpe YE; Sevestre H; Choukroun G; Catherine L; Amant C; Saint F
    Int Urol Nephrol; 2021 Jan; 53(1):59-67. PubMed ID: 32783115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can aquaporin-1 and adipophilin in urine distinguish between malignant and nonmalignant renal lesions?
    Kramer MW; Merseburger AS; Tezval H
    Mayo Clin Proc; 2010 Aug; 85(8):768; author reply 768-9. PubMed ID: 20675516
    [No Abstract]   [Full Text] [Related]  

  • 14. Early alteration of urinary exosomal aquaporin 1 and transforming growth factor β1 after release of unilateral pelviureteral junction obstruction.
    Li ZZ; Zhao ZZ; Wen JG; Xing L; Zhang H; Zhang Y
    J Pediatr Surg; 2012 Aug; 47(8):1581-6. PubMed ID: 22901921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary KIM-1 and AQP-1 in patients with clear renal cell carcinoma: Potential noninvasive biomarkers.
    Mijugković M; Stanojević I; Milović N; Cerović S; Petrović D; Jovanović D; Aleksić P; Kovacević B; Andjelić T; Terzic B; Djukić M; Vojvodić D
    Vojnosanit Pregl; 2016 Mar; 73(3):266-72. PubMed ID: 27295912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of aquaporin 1 in primary renal tumors: a prognostic indicator for clear-cell renal cell carcinoma.
    Huang Y; Murakami T; Sano F; Kondo K; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
    Eur Urol; 2009 Oct; 56(4):690-8. PubMed ID: 18930582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipophilin as prognostic biomarker in clear cell renal cell carcinoma.
    Tolkach Y; Lüders C; Meller S; Jung K; Stephan C; Kristiansen G
    Oncotarget; 2017 Apr; 8(17):28672-28682. PubMed ID: 28404922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased abundance of urinary exosomal aquaporin-1 in renal ischemia-reperfusion injury.
    Sonoda H; Yokota-Ikeda N; Oshikawa S; Kanno Y; Yoshinaga K; Uchida K; Ueda Y; Kimiya K; Uezono S; Ueda A; Ito K; Ikeda M
    Am J Physiol Renal Physiol; 2009 Oct; 297(4):F1006-16. PubMed ID: 19640902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and validation of urinary biomarkers for detection of renal cell carcinoma.
    Frantzi M; Metzger J; Banks RE; Husi H; Klein J; Dakna M; Mullen W; Cartledge JJ; Schanstra JP; Brand K; Kuczyk MA; Mischak H; Vlahou A; Theodorescu D; Merseburger AS
    J Proteomics; 2014 Feb; 98():44-58. PubMed ID: 24374379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accurate quantification of urinary metabolites for predictive models manifest clinicopathology of renal cell carcinoma.
    Sato T; Kawasaki Y; Maekawa M; Takasaki S; Shimada S; Morozumi K; Sato M; Kawamorita N; Yamashita S; Mitsuzuka K; Mano N; Ito A
    Cancer Sci; 2020 Jul; 111(7):2570-2578. PubMed ID: 32350988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.